Ningxia Qiyuan Pharmaceutical Co., Ltd. was established in January 2001. It was restructured and merged by the former state-owned enterprise Ningxia pharmaceutical factory and Ningxia traditional Chinese medicine factory. After nearly 20 years of unremitting efforts, the company has developed into a modern large-scale comprehensive biopharmaceutical enterprise at home and abroad.

Relying on the regional advantages of Ningxia suitable for the development of biopharmaceuticals, the company vigorously develops the R & D and production of antibiotic API, vitamin API and corn deep processing. The company's tetracycline API series products are exclusive in the world. Erythromycin API and its synthetic products are currently one of the three largest suppliers in the world. Vitamin C series products occupy a place in the domestic and foreign markets with their scale and quality.

The company is listed as a national high-tech enterprise, and its technology center is a national enterprise technology center. Erythromycin and tetracycline hydrochloride have passed the certification of FDA in the United States, cos and eugmp in Europe, and official quality audits in India, Japan and other countries. The company's vitamin C products have passed the international food certification, such as halal, kosher, etc. The company's products are sold in Europe, South America, Africa, Southeast Asia and dozens of countries and regions. The company's "Qiyuan" registered trademark has been recognized as "famous trademark of Ningxia" by Ningxia Hui Autonomous Region Administration for Industry and Commerce for many times.

The company has won the titles of "AAA pharmaceutical enterprise with integrity" in the autonomous region, "a tax credit unit" in the autonomous region, and "contract abiding and credit respecting enterprise" in the state, autonomous region and Yinchuan city for many times.